These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7524288)

  • 1. Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
    Izzo AA; Mascolo N; Di Urno MV; Autore G; Di Carlo G; Capasso F
    Agents Actions; 1994 May; 41(3-4):140-3. PubMed ID: 7524288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
    Francischi JN; Dias MF; Rocha OA; de Abreu Castro MS; Kiyomi Funayama Tatsuo MA; Farinelli P; Pacheco CM; Ferreira-Alves DL; Sirois P
    Int Arch Allergy Immunol; 1996 Apr; 109(4):398-406. PubMed ID: 8634526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat.
    Jouquey S; Brown NL; Fichelle J; Worcel M
    Agents Actions; 1988 Jul; 24(3-4):297-302. PubMed ID: 2459935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
    Merlos M; Gómez LA; Vericat L; García-Rafanell J; Forn J
    Pharmacology; 1990; 40(4):211-7. PubMed ID: 1697076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterolobin induces rat paw oedema independently of PAF-acether.
    Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by actinomycin D of neurogenic mouse ear oedema.
    Inoue H; Nagata N; Koshihara Y
    Inflamm Res; 1995 Mar; 44(3):125-30. PubMed ID: 7552577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
    Campos MM; Calixto JB
    Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of carrageenin foot oedema by 1,10 -phenanthroline and evidence for the bradykinin as endogenous mediator.
    Capasso F; Balestrieri B; Di Rosa M; Persico P; Sorrentino L
    Agents Actions; 1975 Oct; 5(4):359-63. PubMed ID: 1211310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of 2-methyl-carbamate-PAF induced rat paw oedema.
    Castro-Faria-Neto HC; Silva PM; Martins MA; Silva PS; Henriques MG; Cordeiro RS; Vargaftig BB
    J Pharm Pharmacol; 1990 Mar; 42(3):203-4. PubMed ID: 1974620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of the inflammation induced in the rat paw by carrageenin.
    Crunkhorn P; Meacock SC
    Br J Pharmacol; 1971 Jul; 42(3):392-402. PubMed ID: 4104654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the enhanced paw edema response to carrageenan and dextran in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
    Katz LB; Theobald HM; Bookstaff RC; Peterson RE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):670-7. PubMed ID: 6206225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
    Cirino G; Peers SH; Flower RJ; Browning JL; Pepinsky RB
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3428-32. PubMed ID: 2470103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.
    Henriques MG; Weg VB; Martins MA; Silva PM; Fernandes PD; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1990 Jan; 99(1):164-8. PubMed ID: 2331569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
    Campos MM; Souza GE; Calixto JB
    Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.
    Henriques MG; Rae GA; Cordeiro RS; Williams TJ
    Br J Pharmacol; 1992 Jul; 106(3):579-82. PubMed ID: 1504742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some pharmacodynamic properties of carrageenin in the rat.
    Di Rosa M; Sorrentino L
    Br J Pharmacol; 1970 Jan; 38(1):214-20. PubMed ID: 4391733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
    Sipka S; Koltai M; Braquet P; Szegedi G
    Int Arch Allergy Immunol; 1992; 97(1):89-92. PubMed ID: 1582704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina.
    Henriques MG; Fernandes PD; Weg VB; Yunes RA; Cordeiro RS; Calixto JB
    Agents Actions; 1991 Jul; 33(3-4):272-8. PubMed ID: 1719783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
    Cordeiro RS; Martins MA; Silva PM; Faria Neto HC; Castanheira JR; Vargaftig BB
    Life Sci; 1986 Nov; 39(20):1871-8. PubMed ID: 3773645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.